Traws Pharma (TRAW) S-3 Shelf registration

Exhibit 107

CALCULATION OF FILING FEE TABLES

Form S-3

(Form Type)

Traws Pharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered (1)	Proposed Maximum Offering Price Per Share (2)	Proposed Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Newly Registered Securities
Fees to be Paid	Equity	Common Stock, $0.01 par value per share	Rule 457(c)	7,230,301	$8.19	$59,216,165.19	$0.00015310	$9,065.99
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities
	Total Offering Amounts						$0.00015310	$9,065.99
	Total Fees Previously Paid							-
	Total Fees Offsets							-
	Net Fee Due							$9,065.99

(1) Represents the shares of common stock, par value $0.01 per share (“Common Stock”), of Traws Pharma, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to the prospectus contained in the Registration Statement on Form S-3 (the “Registration Statement”) to which this exhibit is attached. The Registration Statement registers an aggregate of 7,230,301 shares of Common Stock, which consist of (i) 3,311,052 shares of Common Stock issuable upon exercise of pre-funded warrants and (ii) 3,919,249 shares of Common Stock issuable upon exercise of Series A Warrants. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement shall also cover any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.

(2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices for the Common Stock, as reported on the Nasdaq Capital Market on January 10, 2025, a date within five business days prior to the filing of the Registration Statement.